Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:13 PM UTC
| NCT Number | NCT07463807 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 162 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07463807 is currently recruiting participants. This phase1 study for recurrent multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07463807 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07463807 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.